EFTA01493174.pdf

FINANCIAL TRUST COMPANY INC ACCT. For the Period 6/1/12 to 6/30/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized GainiLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quality Value Original Cost Gain/Loss Accrued iv. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 17.21 18,535.000 284,567.35 251,475.52 33,091.83 04033A-10-0 ARIA BIOGEN IDEC INC 144.38 2,095 000 302,476.10 250,454.95 52,021.15 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 68.89 1.003000 000 888,870.00 1,000,000.00 (311,130.00) 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07,1511 MS 21 09 2515A1-A7-6 FACEBOOK INC-A 31.10 35,000.000 1,088,325.00 1,330,000.00 (241,675.00) 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 100.22 3,000,000.000 3,006,570.00 3,000,000.00 6,570.00 80% CONTIN BARRIER- 10.5%CPN 15% CAP INITIAL LEVEL-6/20/12 SPX:1355.69 38143U-Z9-5 HSBC MARKET PLUS SPX 06117113 99.38 5,000,003.000 4,989,000.00 5,000,000.00 (31,000.00) 72% KO BARRIER- 0%CPN ,UNCAPPED INITIAL LEVEL-02/14112 SPX:1350.50 4042K1-X0-1 JP Morgan ACCOInne199 5 of 34 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan JPM-SDNY-00016014 Chase CONFIDENTIAL SDNY_GM_00285212 EFTA01493174